Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Science & Technology Corp. provides scientific, technical, and engineering services. The firm Specializes in defense chemical and biological research, test and evaluation, range support services, earth and space sciences, polar technologies, aerospace engineering and information systems engineering and support. The company was founded in 1979 and is headquartered in Hampton, VA.

Atriva Therapeutics is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections. Atriva Therapeutics completed preclinical development of ATR-002 and recently filed a request for scientific advice from a European regulatory authority to provide guidance on the executed preclinical development program and the planned ATR-002 Phase I study in healthy volunteers.

The United States Army Medical Research Institute of Infectious Diseases (USAMRIID; pronounced: you-SAM-rid) is the U.S Army's main institution and facility for defensive research into countermeasures against biological warfare. It is located on Fort Detrick, Maryland and is a subordinate lab of the U.S. Army Medical Research and Materiel Command (USAMRMC), headquartered on the same installation.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

CJ Corporation (Korean: 씨제이㈜) is a South Korean conglomerate holding company headquartered in Seoul. It comprises numerous businesses in various industries of food and food service, pharmaceutics and biotechnology, entertainment and media, home shopping and logistics. CJ Group was originally a branch of Samsung until it separated in the 1990s.

ImmuneMed, Inc. develops anti-virus substances and other health related research. The firm’s products include Leptospira RAPID, Scrub Typhus, AFI, Hanta, and Murine Typhus RAPID. The company was founded by Yoon-Won Kim in 2000 and is headquartered in Chuncheon, South Korea.

Eurocine Vaccines AB engages in the research and development of nasal influenza vaccine for children and adult. Its technology, Endocine used to develop a patent protected nasal influenza vaccine for children. The company was founded in 1999 and is headquartered in Solna, Sweden.

Dongshin Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines. The company was founded on April 9, 1970 and is headquartered in Seoul, South Korea.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden.

MIBR is developing treatments and vaccines for rare diseases, autoimmune diseases, infectious diseases, cancers, etc. novel drug development using artificial intelligence pursuing the goals of developing new drugs and improving public health on a global scale

Shutai Shen (Beijing) Biopharmaceutical is a company independently developed a new class of drugs. The company is mainly engaged in the R&D, production and marketing of innovative intellectual property rights. It belongs to the “C27 Pharmaceutical Manufacturing” category in the industry classification of listed companies of the China Securities Regulatory Commission. It is an early exploration research, drug discovery, process development and The pilot-scale amplification, pre-clinical biological evaluation, clinical development, pharmaceutical production and commercialization of the entire industry chain of innovative bio-pharmaceutical enterprises, with a complete system of research and development, production and marketing, is a national high-tech enterprise.